GLP

Etching a New Chapter Enterprise AI Solution in the APAC region

Retrieved on: 
Tuesday, August 1, 2023

Trescon is set to organize the 42nd edition of World AI Show, a global platform showcasing the latest trends and innovations in enterprise AI solutions.

Key Points: 
  • Trescon is set to organize the 42nd edition of World AI Show, a global platform showcasing the latest trends and innovations in enterprise AI solutions.
  • The globally recognized event is set to highlight the latest trends and innovations in enterprise AI solution from top tech leaders, enterprises and governments from the APAC region.
  • We are looking forward to the groundbreaking discussions and witness firsthand the remarkable potential of AI in enterprise solutions."
  • I look forward to sharing best practices and take part in in-depth discussions in the upcoming World AI Show in Singapore."

GLP's new global data center business breaks ground on its first campus in Tokyo, Japan

Retrieved on: 
Thursday, August 10, 2023

Building 1 represents the first phase of the three-building campus and is expected to be ready for service by February 2025.

Key Points: 
  • Building 1 represents the first phase of the three-building campus and is expected to be ready for service by February 2025.
  • It is designed to meet both hyperscale and enterprise customer requirements for physical and cyber security, safety, reliability, and sustainability.
  • Combined with experienced local professionals, the team is well-equipped to provide full-scale data center technical expertise in design, delivery, and operations.
  • "This groundbreaking marks our first data center facility in this region and represents a significant milestone as we further establish our digital infrastructure business to be a leading provider in Japan.

GLP's new global data center business breaks ground on its first campus in Tokyo, Japan

Retrieved on: 
Thursday, August 10, 2023

Building 1 represents the first phase of the three-building campus and is expected to be ready for service by February 2025.

Key Points: 
  • Building 1 represents the first phase of the three-building campus and is expected to be ready for service by February 2025.
  • It is designed to meet both hyperscale and enterprise customer requirements for physical and cyber security, safety, reliability, and sustainability.
  • Combined with experienced local professionals, the team is well-equipped to provide full-scale data center technical expertise in design, delivery, and operations.
  • "This groundbreaking marks our first data center facility in this region and represents a significant milestone as we further establish our digital infrastructure business to be a leading provider in Japan.

Assembly Biosciences Reports Second Quarter 2023 Financial Results and Recent Updates

Retrieved on: 
Wednesday, August 9, 2023

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today reported financial results and recent updates for the second quarter ended June 30, 2023.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today reported financial results and recent updates for the second quarter ended June 30, 2023.
  • “In parallel, our research organization continues to progress towards a second development candidate nomination, which we expect later this year.
  • Assembly Bio’s cash position is projected to fund operations through the third quarter of 2024.
  • General and administrative expenses were $5.0 million for the three months ended June 30, 2023, compared to $6.8 million for the same period in 2022.

DeFi Lending Protocol Dolomite Launches ⚡Zap for One-Click Collateral

Retrieved on: 
Tuesday, August 8, 2023

British Virgin Islands, August 8, 2023 – Dolomite , the lending protocol for efficient capital deployment, has announced ⚡Zap , a one-step collateral solution.

Key Points: 
  • British Virgin Islands, August 8, 2023 – Dolomite , the lending protocol for efficient capital deployment, has announced ⚡Zap , a one-step collateral solution.
  • This first-of-its-kind feature enables DeFi users to increase their collateral against leveraged assets on demand.
  • Users on the Arbitrum network have the ability to borrow against a wide range of assets using Dolomite’s advanced lending protocol, often including assets not found on other lending protocols.
  • ⚡Zap will pave the way for further products that Dolomite is developing based upon this capability while cementing its position as the most innovative lending protocol on Arbitrum.

EQS-News: Heidelberg Pharma AG: Heidelberg Pharma’s Partner Takeda Reached Development Milestone

Retrieved on: 
Tuesday, August 8, 2023

Ladenburg, Germany, 8 August 2023 – Heidelberg Pharma AG (FSE: HPHA) announced today that its partner Takeda reached a development milestone for starting a GLP (Good Laboratory Practice) toxicology study for an Antibody Targeted Amanitin Conjugate.

Key Points: 
  • Ladenburg, Germany, 8 August 2023 – Heidelberg Pharma AG (FSE: HPHA) announced today that its partner Takeda reached a development milestone for starting a GLP (Good Laboratory Practice) toxicology study for an Antibody Targeted Amanitin Conjugate.
  • Upon achievement of the milestone, Heidelberg Pharma received a milestone payment.
  • Prof. Andreas Pahl, CSO of Heidelberg Pharma AG, commented: "We are happy that the development of Takeda’s ATAC candidate, an Amanitin-based ADC, is progressing successfully and that the important GLP study was started.
  • In 2022, Takeda exclusively licensed the worldwide development and commercialization rights from Heidelberg Pharma for the use of the ATAC technology with an antibody directed to a defined target and the resulting product candidates.

GLP Capital Partners closes inaugural commingled clean energy strategy with RMB 4 billion in commitments

Retrieved on: 
Tuesday, August 8, 2023

SHANGHAI and SINGAPORE , Aug. 7, 2023 /PRNewswire/ -- GLP Capital Partners ("GCP") has established its first commingled clean energy strategy in China, raising approximately RMB 4 billion in total capital commitments from domestic institutions including National Green Development Fund and feeder funds affiliated with CHN Energy Investment Group, one of China's largest electricity providers and a prominent state-owned enterprise in the energy sector. The overall investment of the fund is expected to reach approximately RMB 20 billion.

Key Points: 
  • The overall investment of the fund is expected to reach approximately RMB 20 billion.
  • The capital raised provides dry powder for renewable energy investments across wind, solar, energy storage infrastructure and related energy management solutions and the fund will target both greenfield projects and acquisitions in these sectors.
  • "This is a significant fundraise for GCP and we are pleased to raise third-party capital from partners who share the same vision for strengthening renewable energy investment," said Teresa Zhuge, Executive Vice Chairman and President, China at GLP Capital Partners.
  • "Renewable energy is one of GLP's key pillars, focusing on facilitating the energy transition across new economy sectors for a sustainable future.

GLP Capital Partners closes inaugural commingled clean energy strategy with RMB 4 billion in commitments

Retrieved on: 
Tuesday, August 8, 2023

SHANGHAI and SINGAPORE, Aug. 8, 2023 /PRNewswire/ -- GLP Capital Partners ("GCP") has established its first commingled clean energy strategy in China, raising approximately RMB 4 billion in total capital commitments from domestic institutions including National Green Development Fund and feeder funds affiliated with CHN Energy Investment Group, one of China's largest electricity providers and a prominent state-owned enterprise in the energy sector. The overall investment of the fund is expected to reach approximately RMB 20 billion.

Key Points: 
  • The overall investment of the fund is expected to reach approximately RMB 20 billion.
  • The capital raised provides dry powder for renewable energy investments across wind, solar, energy storage infrastructure and related energy management solutions and the fund will target both greenfield projects and acquisitions in these sectors.
  • "This is a significant fundraise for GCP and we are pleased to raise third-party capital from partners who share the same vision for strengthening renewable energy investment," said Teresa Zhuge, Executive Vice Chairman and President, China at GLP Capital Partners.
  • "Renewable energy is one of GLP's key pillars, focusing on facilitating the energy transition across new economy sectors for a sustainable future.

Signati™️ Medical, Inc. Announces Dr. LeRoy Jones Has Been Appointed to Its Board of Directors

Retrieved on: 
Thursday, August 3, 2023

Providence, RI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Signati™️ Medical, Inc. announced today that Dr. LeRoy Jones has been appointed to its Board of Directors.

Key Points: 
  • Providence, RI, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Signati™️ Medical, Inc. announced today that Dr. LeRoy Jones has been appointed to its Board of Directors.
  • Dr. Jones is considered an authority in the field of sexual medicine, having performed over 3000 prosthetic surgeries.
  • Dr. Jones is internationally recognized and has taught surgery in over 26 countries throughout the world.
  • Dr. Jones is currently in private practice with Urology San Antonio in San Antonio, Texas.

Voyager Therapeutics Reports Second Quarter 2023 Financial and Operating Results

Retrieved on: 
Thursday, August 3, 2023

CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today reported second quarter 2023 financial and operating results.

Key Points: 
  • ET today -
    CAMBRIDGE, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today reported second quarter 2023 financial and operating results.
  • Collaboration Revenues: Voyager had collaboration revenue of $4.9 million for the second quarter of 2023, compared to $0.7 million for the same period in 2022.
  • The increase was primarily due to revenue recognized during the second quarter of 2023 on the 2023 and 2019 strategic collaborations with Neurocrine Biosciences.
  • ET to discuss the second quarter 2023 financial and operating results.